| Literature DB >> 28774036 |
Guihua Cui1,2, Zhengguo Gao3, Nannan Qiu4, Toshifumi Satoh5, Toyoji Kakuchi6, Qian Duan7.
Abstract
Regioselective modification ofEntities:
Keywords: ">d-glucosamine (GA); atom transfer radical polymerization (ATRP); lower critical solution temperature (LCST); poly(N-isopropylacrylamide) (PNIPAM)
Year: 2016 PMID: 28774036 PMCID: PMC5457247 DOI: 10.3390/ma9110913
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Scheme 1GA-PNIPAM (i) and (ii) synthesis by ATRP.
Polymerization of GA-PNIPAM (i) and (ii).
| Time (h) | GA-PNIPAM (i) | GA-PNIPAM (ii) | ||||
|---|---|---|---|---|---|---|
| Conversion (%) | Conversion (%) | |||||
| 1 | 12.7 | 1710 | 1.17 | 11.6 | 1570 | 1.14 |
| 3 | 22.5 | 2590 | 1.14 | 20.1 | 2340 | 1.09 |
| 6 | 48.3 | 4190 | 1.18 | 49.4 | 4430 | 1.10 |
| 9 | 58.8 | 4880 | 1.16 | 61.5 | 5620 | 1.17 |
| 12 | 69.6 | 6100 | 1.14 | 69.3 | 6680 | 1.15 |
a Determined by GPC using polystyrene standards.
Figure 1GPC traces of (A) GA-PNIPAM (i); (B)GA-PNIPAM (ii) obtained through ATRP.
Figure 21HNMR spectra of (a) the GA initiator (i) and (b) GA-PNIPAM (i), both in CDCl3.
Figure 31HNMR spectra of (a) GA initiator (ii) and (b) GA-PNIPAM (ii), both in CDCl3.
Figure 4FT-IR spectra of (a) GA; (b) GA-PNIPAM (ii); (c) GA-PNIPAM (i).
Characteristics of GA-PNIPAM (i) and (ii).
| Sample | Time (h) | GA-PNIPAM (i) | GA-PNIPAM (ii) | ||||
|---|---|---|---|---|---|---|---|
| GA (%) | LCST (°C) | GA (%) | LCST (°C) | ||||
| P1 | 1 | 1710 | 19.19 | 43.6 | 1570 | 20.01 | 43.7 |
| P2 | 3 | 2590 | 12.67 | 42.1 | 2340 | 13.42 | 41.8 |
| P3 | 6 | 4190 | 7.83 | 38.8 | 4430 | 7.09 | 38.1 |
| P4 | 9 | 4880 | 6.72 | 36.9 | 5620 | 5.59 | 36.6 |
| P5 | 12 | 6100 | 5.37 | 34.7 | 6680 | 4.70 | 34.5 |
a Determined by GPC using polystyrene standards.
Figure 5Temperature dependence of optical transmittance at wavelength of 500 nm obtained for aqueous solutions of (A) GA-PNIPAM (i) and (B) GA-PNIPAM (ii) (1 mg/mL).
Figure 6Cell viability of the (A) L-929 cells and (B) HepG2 cells incubated with the samples (PNIPAM homopolymer, GA-PNIPAM (i) and (ii); a range of sample concentrations from 0.1 to 1000 μg/mL) by MTT assay for 48 h; and the (C) HepG2 cells exposed to increasing concentrations of samples for different times; (D) Images of HepG2 cells with reference group (D-1), GA group (D-2) and GA-PNIPAM group (ii) (D-3) under microscope.